SS 02 - GI 1: The OPERATIC Side of Rectal Cancer - Organ Preservation, Evaluating Recurrences, and the Immune Checkpoints

Presentations

• 02:30pm - 02:40pm PT

  Quality of Life and 5-Year Long-Term Organ Preservation in Early Rectal Adenocarcinoma Final Results from the OPERA Trial

  Speaker: Nicolas Barbet, MD - ORLAM, villeurbanne
• 02:40pm - 02:50pm PT

  Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial

  Speaker: Hyun Kim, MD - Washington University School of Medicine, St. Louis
• 02:50pm - 03:00pm PT

  Comparison of Patterns of Locoregional Recurrence in Total Neoadjuvant Therapy vs. Chemoradiotherapy for Locally Advanced Rectal Cancer in the STELLAR Study

  Speaker: Jiacheng Shuai, MD - Peking Union Medical College Hospital, Beijing
• 03:00pm - 03:10pm PT

  IMPARC: A Prospective Trial of Stereotactic Proton Reirradiation for Locoregionally Recurrent Rectal Cancer

  Speaker: Poonam Dalwadi, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis
• 03:10pm - 03:20pm PT

  Perioperative Chemotherapy Duration Affects the Survival of Locally Advanced Rectal Cancer: A Post-Hoc Analysis of a Multicenter Randomized, Phase III Trial

  Speaker: Tongzhen Xu, MD - Cancer Hospital, Chinese Academy of Medical Science, Bejing
• 03:20pm - 03:30pm PT

  Efficacy and Safety of Short-Course Radiotherapy followed by Sequential Chemotherapy and AK104 in Locally Advanced Rectal Cancer: Results from a Prospective, Multicenter Phase II Trial

  Speaker: Tongzhen Xu, MD - Cancer Hospital, Chinese Academy of Medical Science, Bejing
• 03:30pm - 03:40pm PT

  Discussant

  Speaker: Jeffrey Olsen, MD - University of Colorado School of Medicine, Aurora